Head and neck cancer is the 6th most common type of cancer in Europe with more than 150,000 new patients diagnosed in 2012, and the incidence of the disease is on the rise. There is little awareness of head and neck cancer among the general public and the healthcare community in Europe, meaning many cases are identified in the late stages which drastically reduces the patient’s chance of survival. Despite major advances in the treatment of head and neck cancers over the past three decades, patient outcomes remain disappointingly unchanged.

When: 17 & 18 September

Venue: CEN-CENELEC Meeting Centre, Avenue Marnix 17, 1000 Brussels, Belgium

Registrations: Registrations are open. We encourage you to send your registration form and save your seat at your earliest convenience.

Objectives of the training

StandarDays give a clear and structured overview of the European Standardization System, of the CEN and CENELEC products and processes, as well as the benefits of involvement to potential stakeholders.

Format